Healthcare Infection Control Practices Advisory Committee (HICPAC), 28392 [2012-11547]
Download as PDF
<![CDATA[
28392
Federal Register / Vol. 77, No. 93 / Monday, May 14, 2012 / Notices
Æ The solution will accept output
from a wide range of ophthalmic
devices and input formats, and convert
to standard DICOM formats (e.g. using
freeware tools).
D Usability and interface for image
viewing
Æ The solution will have an easyto-use interface for clinicians with a
range of experience and comfort level
with technology.
Æ The solution will provide the
ability to view and annotate diagnosticquality ophthalmic images.
D Integration with workflow
Æ The solution will be convenient
to integrate into clinical ophthalmology
workflow, to install on existing office
hardware platforms, and to integrate
with existing EHR systems (e.g. ‘‘single
sign-on’’).
D Platform Neutrality
Additional Information
Ownership of intellectual property is
determined by the following:
D Each entrant retains title and full
ownership in and to their submission.
Entrants expressly reserve all
intellectual property rights not
expressly granted under the challenge
agreement.
D By participating in the challenge,
each entrant hereby irrevocably grants
to Sponsor and Administrator a limited,
non-exclusive, royalty free, worldwide,
license and right to reproduce,
publically perform, publically display,
and use the Submission to the extent
necessary to administer the challenge,
and to publically perform and
publically display the Submission,
including, without limitation, for
advertising and promotional purposes
relating to the challenge.
Dated: May 7, 2012.
Farzad Mostashari,
National Coordinator for Health Information
Technology.
[FR Doc. 2012–11591 Filed 5–11–12; 8:45 am]
emcdonald on DSK29S0YB1PROD with NOTICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Alcohol-related Motor Vehicle
Injury Research, FOA CE12–006, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
Jkt 226001
[FR Doc. 2012–11546 Filed 5–11–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
14:46 May 11, 2012
Dated: May 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
BILLING CODE 4150–45–P
VerDate Mar<15>2010
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
TIME AND DATE: 12 p.m.–2:30 p.m., June
12, 2012 (Closed).
PLACE: Teleconference.
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
MATTERS TO BE DISCUSSED: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Alcohol-related Motor Vehicle Injury
Research, FOA CE12–006, initial
review.’’
CONTACT PERSON FOR MORE INFORMATION:
Jane Suen, Dr.P.H., M.S., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341–3724, Telephone (770)
488–4281.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
TIMES AND DATES: 9:00 a.m.–5:00 p.m.,
June 14, 2012.
9:00 a.m.–12:00 p.m., June 15, 2012.
PLACE: CDC, Global Communications
Center, Building 19, Auditorium B3,
1600 Clifton Road NE., Atlanta, Georgia,
30333
PO 00000
Frm 00044
Fmt 4703
Sfmt 9990
Open to the public, limited
only by the space available. Please
register for the meeting at www.cdc.gov/
hicpac.
PURPOSE: The Committee is charged
with providing advice and guidance to
the Secretary, the Assistant Secretary for
Health and Human Services, the
Director, CDC, the Director, National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), and the
Director, Division of Healthcare Quality
Promotion regarding 1) the practice of
healthcare infection control; 2)
strategies for surveillance, prevention,
and control of infections (e.g.,
nosocomial infections), antimicrobial
resistance, and related events in settings
where healthcare is provided; and 3)
periodic updating of guidelines and
other policy statements regarding
prevention of healthcare-associated
infections (HAIs) and healthcare-related
conditions.
MATTERS TO BE DISCUSSED: The agenda
will include updates on CDC’s activities
for HAIs including outbreaks and
guidance on the use of single-dose vials;
draft guideline for prevention of
infections among patients in neonatal
intensive care units (NICU); draft
guideline for management of
occupational exposures to HIV and
recommendations for post-exposure
prophylaxis; draft guidance for facility
adjudication of infection data; and an
update on National HealthCare Safety
Network (NHSN) validation and
surveillance definitions for central-line
associated bloodstream infections and
surgical site infections. Time will be
available for public comment.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Erin Stone, M.S., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, l600 Clifton Road NE., Mailstop
A–07, Atlanta, Georgia, 30333,
Telephone (404) 639–4045, Email:
hicpac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
STATUS:
Dated: May 3, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–11547 Filed 5–11–12; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\14MYN1.SGM
14MYN1
]]>Agencies
[Federal Register Volume 77, Number 93 (Monday, May 14, 2012)]
[Notices]
[Page 28392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11547]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates: 9:00 a.m.-5:00 p.m., June 14, 2012.
9:00 a.m.-12:00 p.m., June 15, 2012.
Place: CDC, Global Communications Center, Building 19, Auditorium B3,
1600 Clifton Road NE., Atlanta, Georgia, 30333
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and guidance to
the Secretary, the Assistant Secretary for Health and Human Services,
the Director, CDC, the Director, National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), and the Director, Division of
Healthcare Quality Promotion regarding 1) the practice of healthcare
infection control; 2) strategies for surveillance, prevention, and
control of infections (e.g., nosocomial infections), antimicrobial
resistance, and related events in settings where healthcare is
provided; and 3) periodic updating of guidelines and other policy
statements regarding prevention of healthcare-associated infections
(HAIs) and healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on CDC's
activities for HAIs including outbreaks and guidance on the use of
single-dose vials; draft guideline for prevention of infections among
patients in neonatal intensive care units (NICU); draft guideline for
management of occupational exposures to HIV and recommendations for
post-exposure prophylaxis; draft guidance for facility adjudication of
infection data; and an update on National HealthCare Safety Network
(NHSN) validation and surveillance definitions for central-line
associated bloodstream infections and surgical site infections. Time
will be available for public comment.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia, 30333, Telephone (404) 639-
4045, Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: May 3, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-11547 Filed 5-11-12; 8:45 am]
BILLING CODE 4163-18-P
